Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon

0Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Metabolomics provides a powerful tool to study physiological changes in response to various perturbations such as vaccination. We explored whether metabolomic changes could be seen after vaccination in a phase I trial where Gabonese adults living either in rural or semi-urban areas received the subunit hookworm vaccine candidates (Na-GST-1 and Na-APR-1 (M74) adjuvanted with Alhydrogel plus GLA-AF (n = 24) or the hepatitis B vaccine (n = 8) as control. Urine samples were collected and assayed using targeted 1H NMR spectroscopy. At baseline, a set of metabolites significantly distinguished rural from semi-urban individuals. The pre- and post-vaccination comparisons indicated significant changes in few metabolites but only one day after the first vaccination. There was no relationship with immunogenicity. In conclusion, in a small phase 1 trial, urinary metabolomics could distinguish volunteers with different environmental exposures and reflected the safety of the vaccines but did not show a relationship to immunogenicity.

Cite

CITATION STYLE

APA

Ongwe, M. E. B., Mouwenda, Y. D., Stam, K. A., Kremsner, P. G., Lell, B., Diemert, D., … Yazdanbakhsh, M. (2022). Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon. PLoS ONE, 17(9 September). https://doi.org/10.1371/journal.pone.0275013

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free